These cells, which can be isolated from all CML patients in CP, are phenotypically primitive expressing the stem cell marker, CD34, and are part of the leukaemic clone being BCR-ABL+ by RT-PCR and Ph+ by FISH. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.